The Lymphoma Channel is supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze).
The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
CAR-T Meeting 2021 | Keynote lectures and BiTE vs CAR-T debate
Nicolaus Kröger, MD, University Medical Center Hamburg, Hamburg, Germany, describes what he is looking forward to from the upcoming European CAR T-cell Meeting 2021, including the keynote lectures from world-renowned leaders in the field, who will present their most recent work and discuss the expected developments in the near future. Additionally, Prof. Kröger highlights the session comparing CAR T-cell therapy and bispecific T-cell engagers (BiTEs). This interview was recorded during an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
